Search research articles
Contact Us
Filters
Showing results (271-280 of 316) with videos related to
Page
of 32
Sort By:
JAMA Dermatology
|
May 25, 2022
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus
Junwen Deng, Varsha Parthasarathy, Waleed Adawi, et al.
European Journal of Heart Failure
|
February 26, 2024
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy
Martina Setti, Marco Merlo, Marta Gigli, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 4, 2005
Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy
Y Joseph Woo, Todd J Grand, Mark F Berry, et al.
Animals : an Open Access Journal From MDPI
|
October 28, 2023
An Experimental Field Trial Investigating the Use of Bacteriophage and Manure Slurry Applications in Beef Cattle Feedlot Pens for <i>Salmonella</i> Mitigation
Colette A Nickodem, Ashley N Arnold, Matthew R Beck, et al.
Science Advances
|
December 13, 2023
Parkinson's VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B
Prosenjit Pal, Matthew Taylor, Pui Yiu Lam, et al.
The Lancet. Oncology
|
March 30, 2019
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
Vicky Makker, Drew Rasco, Nicholas J Vogelzang, et al.
Research Square
|
December 23, 2022
Antiviral response mechanisms in a Jamaican Fruit Bat intestinal organoid model of SARS-CoV-2 infection
Marziah Hashimi, Thomas Sebrell, Jodi Hedges, et al.
Trials
|
March 17, 2018
The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trial
Til Wykes, Eileen Joyce, Tjasa Velikonja, et al.
Journal for Immunotherapy of Cancer
|
September 10, 2020
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study
Claire F Verschraegen, Guy Jerusalem, Edward F McClay, et al.
American Journal of Hematology
|
January 21, 2018
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
Carlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 316) with videos related to
Sort By:
Page
of 32
JAMA Dermatology
|
May 25, 2022
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus
Junwen Deng, Varsha Parthasarathy, Waleed Adawi, et al.
European Journal of Heart Failure
|
February 26, 2024
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy
Martina Setti, Marco Merlo, Marta Gigli, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 4, 2005
Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy
Y Joseph Woo, Todd J Grand, Mark F Berry, et al.
Animals : an Open Access Journal From MDPI
|
October 28, 2023
An Experimental Field Trial Investigating the Use of Bacteriophage and Manure Slurry Applications in Beef Cattle Feedlot Pens for <i>Salmonella</i> Mitigation
Colette A Nickodem, Ashley N Arnold, Matthew R Beck, et al.
Science Advances
|
December 13, 2023
Parkinson's VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B
Prosenjit Pal, Matthew Taylor, Pui Yiu Lam, et al.
The Lancet. Oncology
|
March 30, 2019
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
Vicky Makker, Drew Rasco, Nicholas J Vogelzang, et al.
Research Square
|
December 23, 2022
Antiviral response mechanisms in a Jamaican Fruit Bat intestinal organoid model of SARS-CoV-2 infection
Marziah Hashimi, Thomas Sebrell, Jodi Hedges, et al.
Trials
|
March 17, 2018
The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trial
Til Wykes, Eileen Joyce, Tjasa Velikonja, et al.
Journal for Immunotherapy of Cancer
|
September 10, 2020
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study
Claire F Verschraegen, Guy Jerusalem, Edward F McClay, et al.
American Journal of Hematology
|
January 21, 2018
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
Carlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, et al.
Page
of 32